BRIEF-Novo Nordisk Cagrisema 1.7 Mg/1.7 Mg Achieved 20.7%, 1.0 Mg/1.0 Mg Achieved 21.0% Average Weight Loss At 68 Weeks Versus 2.0% With Placebo In Redefine 9 Trial

Reuters · 1d ago

Please log in to view news